BioNTech SE - ADR vs Vanguard S&P 500 ETF — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Vanguard S&P 500 ETF trades at $709.92. The key difference: Vanguard S&P 500 ETF is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | VOO | |
|---|---|---|
Market Cap | $23.31B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $119.34 | $710.71 |
52-Week Low | $83.89 | $580.93 |
Enterprise Value | $6.60B | — |
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →VOO is a foundational ETF that tracks the S&P 500 Index, providing exposure to 500 of the largest and most established companies in the United States. Renowned for its ultra-low expense ratio and tax efficiency, it serves as a core building block for long-term investors seeking to capture the total return of the U.S. large-cap market in a single, highly liquid vehicle.
Read more on VOO →